ExLibris header image
SFX Logo
Title: Toward drugs derived from cannabis
Source:

Naturwissenschaften [0028-1042] Mechoulam, R yr:1978


Collapse list of basic services Basic
Full text
Full text available via SpringerLINK Contemporary 1997-Present
GO
Full text available via SpringerLink Historical Archives Biomedical and Life Sciences
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Ames, F R. "Anticonvulsant effect of cannabidiol." SAMJ. South African medical journal 69.1 (1986): 14-14. Link to SFX for this item
2. Cunha, R M. "Chronic administration of cannabidiol to healthy volunteers and epileptic patients." Pharmacology 21.3 (1980): 175-85. Link to SFX for this item
3. Wade, D T T. "Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis." Multiple sclerosis 12.5 (2006): 639-45. Link to Full Text for this item Link to SFX for this item
4. Razdan, R K. "Steroidal analog of a tetrahydrocannabinol." Journal of medicinal chemistry 11.2 (1968): 377-. Link to Full Text for this item Link to SFX for this item
5. Cowan, C. "Banned in the USA: federal law makes it illegal to grow industrial hemp in the United States, but some states have passed bills and resolutions designed to test that ban. Two states have legalized industrial hemp, seven are studying it and five are urging." State government news 45.4 (2002): 26-. Link to SFX for this item
6. Reilly, C. "Depression and anxiety in childhood epilepsy: A review." Seizure 20.8 (2011): 589-597. Link to SFX for this item
7. Carlini, E A A. "Hypnotic and antiepileptic effects of cannabidiol." The Journal of clinical pharmacology 21.8 suppl (1981): 417-427. Link to SFX for this item
8. Vaney, C. "Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study." Multiple sclerosis 10.4 (2004): 417-24. Link to Full Text for this item Link to SFX for this item
9. Zajicek, J. "Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial." The lancet 362.9395 (2003): 1526-26. Link to SFX for this item
10. Wade, Derick T T. "Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients." Multiple sclerosis 10.4 (2004): 434-41. Link to Full Text for this item Link to SFX for this item
11. HUSSAIN, S. "Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox–Gastaut syndrome." Epilepsy & behavior 47.C (2015): 138-141. Link to SFX for this item
12. Bosetti, C. "Artificial sweeteners and the risk of gastric, pancreatic, and endometrial cancers in Italy." Cancer epidemiology biomarkers & prevention 18.8 (2009): 2235-8. Link to SFX for this item
13. Wallace, M.J. J. "The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy." The Journal of pharmacology and experimental therapeutics 307.1 (2003): 129-137. Link to SFX for this item
14. Centonze,, Diego, D. "Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis." Neurological Sciences 30.6 (2009): 531-534. Link to SFX for this item
15. Collin, C. "Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis." European journal of neurology 14.3 (2007): 290-6. Link to Full Text for this item Link to SFX for this item
16. Jones, Nicholas A. "Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo." The Journal of pharmacology and experimental therapeutics 332.2 (2010): 569-77. Link to SFX for this item
17. Monti,, Jaime M., J. "Hypnoticlike effects of cannabidiol in the rat." Psychopharmacology 55.3 (1977): 263-265. Link to Full Text for this item Link to SFX for this item
18. Abi-Saab, J. "Delta-9-Tetrahydrocannabinol Effects in Schizophrenia: Implications for Cognition, Psychosis, and Addiction." Biological psychiatry 57.6: 594-608. Link to SFX for this item
19. Cunha, J M M. "Effects of cannabidiol in animal models predictive of antipsychotic activity." Psychopharmacology 104.2 (1991): 260-4. Link to Full Text for this item Link to SFX for this item
20. "Personal protective equipment needs in the USA during the COVID-19 pandemic." The lancet (North American edition) 395.10237. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.